They had guidance on $50m from memory for the financial year which ends 31 March 2023. They would have built into that the CBI rollout at budgeted revenues and timeframes and the SBI contract expiring 31 December 2022.
Subsequent to this we know SBI has been extended for a year, which is the $10m per quarter. The recent announcement said they are in front on the CBI rollout with higher than budgeted transaction volumes. So, to March 23 I would expect revenue in the range of $60-65m, being the guidance of $50m, plus the extra $10m from SBI and assuming CBI rollout remains ahead of schedule with increased transactions as a good case scenario.
Cheers
- Forums
- ASX - By Stock
- FND
- Ann: ATM rollout ahead of schedule for Central Bank of India
FND
findi limited
Add to My Watchlist
0.00%
!
$4.25

Ann: ATM rollout ahead of schedule for Central Bank of India, page-8
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$4.25 |
Change
0.000(0.00%) |
Mkt cap ! $262.6M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
FND (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online